Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic variation in STAT4
predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 63, Issue 4, Pages 1102-1111
Publisher
Wiley
Online
2015-12-25
DOI
10.1002/hep.28423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
- (2015) Barbara Rehermann et al. HEPATOLOGY
- Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis
- (2015) De-Ke Jiang et al. Scientific Reports
- Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
- (2014) E. Galmozzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN- in Lupus Patients In Vivo
- (2014) S. N. Kariuki et al. JOURNAL OF IMMUNOLOGY
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B
- (2014) Haiqing Wu et al. LIVER INTERNATIONAL
- Effect ofHLA-DPandIL28Bgene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients
- (2013) Lin Cheng et al. HEPATOLOGY RESEARCH
- IL28Bgenotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
- (2013) Jacinta A Holmes et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- Effectiveness of Hepatitis B Treatment in Clinical Practice
- (2012) Steven J. Scaglione et al. GASTROENTEROLOGY
- New perspectives in the therapy of chronic hepatitis B
- (2012) Pietro Lampertico et al. GUT
- IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
- (2012) Pietro Lampertico et al. HEPATOLOGY
- Clinical utility of interleukin-28B testing in patients with genotype 1
- (2012) Michelle Lai et al. HEPATOLOGY
- One more piece in the interleukin 28B gene puzzle? The case of hepatitis B
- (2012) Nikolaus Jilg et al. HEPATOLOGY
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
- (2012) Lorenzo Micco et al. JOURNAL OF HEPATOLOGY
- Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma
- (2012) De-Ke Jiang et al. NATURE GENETICS
- Genetics of IL28B and HCV—response to infection and treatment
- (2012) C. Nelson Hayes et al. Nature Reviews Gastroenterology & Hepatology
- Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir
- (2012) A. de Niet et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese
- (2011) Xiaopan Wu et al. ANTIVIRAL RESEARCH
- Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
- (2011) Tai-Chung Tseng et al. ANTIVIRAL THERAPY
- Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B
- (2011) Milan J. Sonneveld et al. GASTROENTEROLOGY
- Benefits and risks of interferon therapy for hepatitis B
- (2010) Robert Perrillo HEPATOLOGY
- Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
- (2009) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
- (2008) A-K Abelson et al. ANNALS OF THE RHEUMATIC DISEASES
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
- (2008) S. Sigurdsson et al. HUMAN MOLECULAR GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now